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 1 
ABSTRACT 2 
Background We have previously reported a non-invasive, semi-automated technique to 3 
assess motility of the wall of the ascending colon (AC) using Magnetic Resonance Imaging. 4 
This study investigated the feasibility of using a tagged MRI technique to visualise and assess 5 
the degree of flow within the human ascending colon in healthy subjects and those suffering 6 
from constipation.  7 
Methods An open-labelled study of 11 subjects with constipation and 11 subjects without 8 
bowel disorders was performed. MRI scans were acquired fasted, then 60 and 120 mins after 9 
ingestion of a 500ml macrogol preparation. The amount of free fluid in the small and large 10 
bowel was assessed using a heavily T2-weighted MRI sequence. The internal movement of 11 
the contents of the AC were visualised using a cine tagged MRI sequence and assessed by a 12 
novel analysis technique. Comparisons were made between fasting and postprandial scans 13 
within individuals, and between the constipation and control groups.  14 
Key results. Macrogol significantly increased the mobile, MR visible water content of the 15 
ascending colon at 60 mins post ingestion compared to fasted data (controls p=0.001, 16 
constipated group p=0.0039). The contents of the AC showed increased motion in healthy 17 
subjects but not in the constipated group with significant differences between groups at 60 18 
minutes (p<0.002) and 120 minutes (p<0.003).  19 
Conclusions and inferences. This study successfully demonstrated the use of a novel MRI 20 
tagging technique to visualise and assess the motion of ascending colon contents following a 21 
500ml macrogol challenge. Significant differences were demonstrated between healthy and 22 
constipated subjects. 23 
 24 
 25 
Pritchard 3 
 26 
 27 
KEY POINTS: 28 
Manometry techniques provide information about pressure changes that occur when the colon 29 
wall contracts. There is little knowledge about how the contents move. 30 
 31 
Using an MRI tagging technique we showed differences in the movement of colonic chyme 32 
(following a macrogol stimulus) between subjects with constipation and healthy controls. 33 
 34 
This non-invasive MRI technique has wide application as a tool to investigate the movement 35 
of colonic contents in constipation and diarrhoea to help further our understanding of the 36 
physiology of the colon. 37 
38 
Pritchard 4 
INTRODUCTION 39 
Constipation is a common  problem worldwide, with estimates of prevalence ranging from 40 
14% to 28% in the USA [1] and associated annual health care costs recently estimated to 41 
exceed $230 million [2]. Generally constipation disorders have been categorised in three 42 
ways [3]: firstly, constipation arising from disordered or obstructed defecation (OC) (where 43 
the primary cause is impaired rectal evacuation) [4], secondly  irritable bowel syndrome with 44 
constipation (IBS-C) accompanied by pain and bloating, often with transit  times within the 45 
wide range of normality, and thirdly, functional slow transit constipation (FC).  As we have 46 
recently shown, although the symptoms overlap substantially, these conditions have different 47 
mechanisms of disease [5] and may require different treatments. Distinguishing these 48 
conditions based mostly on patient perception leads to trial and error treatments which may 49 
explain why 50% of patients are dissatisfied with their treatment [6]. 50 
We showed previously that, while baseline measurements do differ, the contrast between 51 
patient groups can be enhanced by stressing the colon using an osmotic laxative to distend the 52 
ascending colon, so that 1 hour after ingestion of 1 litre of a macrogol drink, colonic volumes 53 
become abnormal in 19/20 FC patients [7]. 54 
In our previous work, using cine MRI to determine colonic wall motility, it was clear that 55 
there was also motion occurring within the colonic contents, probably related to the gross 56 
movement and mixing of these contents.  MRI tagging is commonly used for the assessment 57 
of cardiac function and has been applied previously to monitor small bowel motility [8, 9] 58 
and to study movement of the stomach contents following a porridge meal [10].  59 
 60 
In this study, we aimed to investigate whether an MRI tagging technique could be used to 61 
assess movement within in the human ascending colon and to differentiate between the 62 
colonic response to a 500ml macrogol oral stimulus in healthy and constipated subjects. 63 
 64 
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METHODS 65 
Subjects and study design 66 
The study protocol was approved by the Local Research Ethics Committee (control group: 67 
G08052014 SoM NDDC and constipated group: J14082014 SoM NDDC). Twenty two 68 
subjects were recruited by advertisement and from a database of subjects who had taken part 69 
in previous studies and had agreed to be contacted again. All subjects gave written informed 70 
consent and had no contraindications to MRI. There were no adverse events during the 71 
studies. 72 
The 11 healthy participants had no history of gastrointestinal disease. There were 4 males and 73 
7 females, aged 28 ± 10 years (mean ± standard deviation) with mean Body Mass Index 74 
(BMI) 25 ± 5 kg m-2. The 11 constipated participants (as defined by Rome III criteria) were 2 75 
males and 9 females aged 36 ± 13 years, with BMI 25 ± 5kg m-2.   Constipated subjects were 76 
asked to refrain from taking their usual laxatives for two days before the MRI study day. 77 
All subjects ingested 5 MRI transit marker capsules as described previously [11, 12] 24 hours 78 
prior to MRI. Subjects were asked to avoid strenuous exercise and ingesting alcohol and 79 
caffeine the day before their attendance for MRI, and to fast from 22:00 hours the previous 80 
evening. They were only allowed to consume a small glass of water on waking on the day of 81 
the experiment. Participants completed a questionnaire to investigate adherence to the study 82 
restrictions before acquiring the baseline, fasted MRI scan. They were then asked to drink a 83 
500ml dose of MOVIPREP® (Norgine Pharmaceuticals Ltd, Harefield, UK) polyethylene 84 
glycol (Macrogol 3550) electrolyte solution within 30 minutes.  The time the subjects started 85 
consuming the test drink was defined as t=0. This was followed by a scan at t= 60 mins and 86 
t=120 mins. 87 
 88 
Magnetic Resonance Imaging 89 
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All MRI scans were carried out using a 3T Philips Achieva scanner (Philips, Best, The 90 
Netherlands). The subjects were positioned supine with a 16-channel XL-torso receiver coil 91 
wrapped around their abdomen. After the initial set-up scans, the following scans were 92 
acquired across the abdomen:- 93 
(1) A multi-echo mDIXON scan [13] was used to determine the location of the transit pills 94 
and calculate a weighted average position  score (WAPS) for each subject (a validated 95 
measure of whole gut transit time) [11, 12]. 96 
(2) A T2-weighted single shot (RARE) sequence was used to determine the mobile, MR 97 
visible water content of both the small bowel (Small Bowel Water Content, SBWC) and 98 
colon [14-17]. This sequence was included to enable monitoring of the progress of the 99 
laxative drink through the GI tract. 100 
(3) To aid in the positioning of the tagged slice through the AC a high resolution multi-slice 101 
bTFE scan was acquired, placed sagitally oblique through the AC [16].  102 
(4) Motion of the contents of the AC were visualized using a tagged bTFE sequence [9] 103 
centered within the ascending colon (primarily sagittal). This sequence superimposed dark 104 
horizontal stripes (tags), 12 mm apart, onto the images. The delay of 250 ms between 105 
application of the tag lines and acquisition of the image allowed movement within the colon 106 
to be detected (see Fig. 1). This sequence had TR/TE 2.3/1.15 ms, FA 45o , with a single 107 
sagittal slice, thickness 15 mm, FOV 222-264 mm (AP), 330 mm (HF) with acquired 108 
resolution of 1.5x1.5 mm2 and reconstructed to 0.98x0.98 mm2, SENSE factor 1.5, and half-109 
scan factor 0.7. In total, 33 dynamic scans were acquired at 600 ms intervals within a single 110 
20 s breath-hold.  111 
All other imaging parameters associated with the different sequences are summarized in 112 
Table (1). 113 
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The subjects spent 30 minutes per time point inside the scanner and they were asked to spend 114 
the rest of the time sitting upright in an adjacent room. 115 
 116 
Data analysis  117 
An overall assessment of gut transit time (WAPS) was obtained by noting the position of 5 118 
marker capsules ingested 24 hrs prior to scanning as previously reported [11, 12].  The free 119 
water in the small bowel (SBWC) and colon were measured using the RARE sequence as 120 
previously described [14, 18]. 121 
 122 
The series of tagged images of the ascending colon provided a method to visualize motion 123 
within the colon and were also used to assess the movement of the colon contents. If no 124 
movement of colonic contents, or adjacent viscera, occurred during the breath hold (eg due to 125 
small respiratory movements or aortic pulsation) then all 33 sequential tagged images would 126 
be identical, with all tag lines remaining straight (as seen in Fig 1a). However any movement 127 
of the colonic chyme in the delay between the application of the tag and acquisition of the 128 
image would change the position of the tag lines on the image. For instance, if laminar flow 129 
was present then each frame would show uniform displacement of each tag line within the 130 
colon, with the displacement proportional to the flow velocity, 12 mm corresponding to a 131 
flow velocity of 4.8 cm/sec in this case.  Laminar flow velocities greater than this value 132 
would not be detected due to the periodicity of the tag lines. The predominant direction of 133 
flow (antegrade or retrograde) would also be revealed from the antegrade (arrowed) or 134 
retrograde direction of displacement of the tagged lines (as can be seen in Fig 1b )  Therefore 135 
the movement of the tags could, in principle, be used to measure laminar flow velocity. 136 
However, as can be seen in Fig. 2, non-laminar flow leads to local variations in the 3D 137 
velocity field which can smear the tag and prevent absolute velocity measurement. This 138 
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provides a simple method to assess movement of the colonic content, since motion, in any 139 
direction, will lead to changes in signal intensity in the tagged colonic contents from frame to 140 
frame. It is this variation in intensity which is the basis of the proposed method of analysing 141 
the data to assess motion within the colonic contents. 142 
 143 
The first 4 frames of each sequence were discarded due to intensity changes occurring as the 144 
MRI signal reached steady state. The mean signal intensity (MI(x,y)) and standard deviation 145 
(STDEV(x,y)) of each pixel through the remaining 29 sequential cine frames were calculated 146 
using IDL® (Research Systems Inc, Boulder, CO)  resulting in maps of both mean intensity 147 
and standard deviation (Figure 2a and b).  148 
 149 
In the standard deviation maps those voxels whose intensity is changed during the 20 seconds 150 
of data acquisition (either by the movement of structures such as the colon wall, or by the 151 
movement or smearing of the null tagged lines) have a larger standard deviation (Fig. 2b) 152 
whereas static structures (liver, muscle and fat) or motionless colonic contents have a value 153 
close to zero (Fig. 2a). The resulting map thus highlights any motion of the colonic contents, 154 
even where the net displacement over 20 seconds could be zero. This standard deviation map 155 
also reveals where the motion is concentrated eg if it is the whole colon that has moved then 156 
all the contents will show a high standard deviation whereas movement in a narrow ‘jet’ will 157 
lead to a smaller region of high intensity within the colon.   In order to derive a single 158 
parameter that easily summarises this motion of the colonic contents a region encompassing 159 
the AC was drawn on the mean intensity map, as shown in figure 2, and the average mean 160 
intensity (MIR) and average STDEV (STDEVR) within that region was calculated (using 161 
Analyze9 TM, Mayo Foundation, Rochester, MN,USA). The average coefficient of variation 162 
(%COV) for the tagged scan is then estimated from  163 
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%COV= 100x STDEVR/ MIR 164 
 165 
Statistics 166 
Normality of the data was tested using D’Agostino Pearson’s normality test and the data are 167 
expressed as mean, (standard deviation) for normally distributed data and median values 168 
(with the IQR indicated in brackets), for non-normally distributed data.  Statistical analysis 169 
was carried out using Prism 6 (GraphPad Software Inc.). Comparisons within group were 170 
performed using a paired t-test (for normally distributed data) or Wilcoxon’s matched-pairs 171 
signed rank test, for data non-normally distributed. Comparisons between groups were 172 
performed using an unpaired t-test (with Welches correction for normally distributed data) or 173 
Mann-Whitney rank sum test for non-normally distributed data. Multiple comparisons of data 174 
were Bonferroni corrected, with comparison between baseline and 60, baseline and 120, for 175 
both cohorts and at all times between groups resulting in a corrected significant p-value of < 176 
0.0071 177 
 178 
RESULTS 179 
All subjects completed the study day. MRI scans were not available for two constipated 180 
subjects at t=60 mins, one healthy volunteer at t=60 mins and one healthy volunteer at t=120 181 
mins due to equipment problems.  182 
 183 
Whole Gut Transit 184 
At baseline the WAPS measured using the MR markers were significantly different between 185 
groups: controls 0.6 (0-1) and constipated group 2.6 (1.4-3.6), p=0.0011 Mann-Whitney rank 186 
sum test.  187 
Free water in the small bowel and ascending colon 188 
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The amount of mobile, free water in the small bowel (SBWC) is shown in Fig. 3a. There was 189 
no significant difference in the fasted baseline values of these groups (controls 33 (22-89) ml, 190 
constipated group 66 (42-124) ml p=0.11). Sixty minutes after macrogol ingestion, the 191 
SBWC was significantly increased in both groups, (controls 372 (220-566) ml p=0.001, 192 
constipated group 472 (337-708) ml p=0.0039; Wilcoxon ranked pairs test). By t=120 193 
minutes SBWC had dropped in both groups (controls 231 (157-322) ml, constipated group 194 
406 (215-517) ml), although the change from baseline remained significant for both groups 195 
(controls p=0.0068, constipated group p=0.001 Wilcoxon ranked pairs test), when multiple 196 
comparisons were taken into account. However there were no significant differences in 197 
SBWC between groups at 60 (p=0.41) and 120 mins (p=0.09) (Mann-Whitney rank sum test). 198 
 199 
The variation in free water content in the ascending colon is shown in Fig. 3b. There was no 200 
significant difference in the very low baseline values between groups (controls 2 (0-7) ml, 201 
constipated group 11 (1-29) ml p=0.16). By 60 mins post ingestion the amount of mobile, 202 
free water was significantly increased in the healthy control groups, (140 (104-347) ml, 203 
p=0.001), and in the constipated group 228 (91-259) ml, p=0.0039 (Wilcoxon ranked pairs 204 
test) showing that the macrogol solution had entered the ascending colon in both groups. By 205 
120 minutes post ingestion the amount of mobile, free water in the ascending colon had only 206 
dropped in the constipated group (controls 146 (32-227) ml, constipated group 84 (3-195) ml) 207 
although the change from baseline was still significant in both groups, (controls p=0.002, 208 
constipated group p=0.0039) when corrected for multiple comparisons. Again there were no 209 
significant differences in the free water in the ascending colon between groups at 60 (p=0.66) 210 
or at 120 mins (p=0.24) (Mann-Whitney rank sum test). 211 
 212 
Tagged Images 213 
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Baseline sequences showed intact tags (as shown in Figs. 1a, 2a and supplementary 214 
information video 1) indicating very little motion within the colon in both groups. After 60 215 
mins displacement and smearing of the tags (as shown in Fig. 1b) was observed in some 216 
subjects (mainly healthy volunteers). Fig. 4a shows the presence of forward and backward tag 217 
displacement occurring simultaneously in the central regions of the ascending colon. Fig. 4b 218 
demonstrates the presence of a fast (>4.8 cm/sec) retrograde central ‘jet’, which was also 219 
observed (supplementary information video 2). Tag smearing resulting from non-1D laminar 220 
flow can be seen as a reduction of tag intensity in Fig. 4c. Increased movement in the central 221 
regions of the ascending colon, compared to that adjacent to the colon walls, (seen in all parts 222 
of Fig. 4) was observed throughout the data sets. Such motion was still visible at t=120 223 
minutes, although predominantly in the healthy subjects rather than the constipated group.  224 
 225 
The calculated average coefficient of variation (%COV) for the all the completed tagged 226 
scans of the ascending colon is shown in Fig. 5. As expected there is no significant difference 227 
in the low baseline values between groups (controls 20% (14-23), constipated group 12% 228 
(11-20); p=0.1). By 60 mins post ingestion the %COV was significantly increased in the 229 
control group only (30% (26-35), p=0.002; constipated group 17% (13-23), p=0.57; 230 
Wilcoxon ranked pairs test). By 120 minutes the %COV had dropped in both groups but the 231 
change from baseline remained significant only for controls (controls 25% (18-36), p=0.002; 232 
constipated group 13.% (12-18), p=0.76). This led to a significant difference in the %COV 233 
between groups at 60 mins (p=0.002) and 120 mins (p=0.003) (Mann-Whitney rank sum test). 234 
 235 
DISCUSSION 236 
MRI tagging and our proposed analysis technique provide a new method to visualize 237 
movement of the colonic contents and a novel means of quantifying this. The technique has 238 
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been used to demonstrate differences between healthy and constipated subjects in response to 239 
a 500ml macrogol challenge.  240 
MRI is an ideal tool to study the physiology of the bowel, allowing assessment of changes in 241 
whole gut transit, contractile activity, and fluid distribution both in the small bowel [9, 14, 15, 242 
19-30] and the colon [11, 12, 21, 22, 31-33] during interventional studies. The whole bowel 243 
(small and large) can be assessed in a single scanning session and, since MRI is non-invasive, 244 
repeated studies are possible.  The additional information gained from the tagging sequence 245 
provides further insights into how the chyme moves within the large bowel. Specifically the 246 
proposed %COV measure relates to the movement and blurring of the tags and therefore 247 
mixing related motion. More sophisticated analysis of this tagged data might allow more 248 
detailed assessment of the velocity fields within the colon.  Additional blurring of the tag 249 
lines could arise from motion occurring during the readout phase of the acquisition and will 250 
have contributed to the variance measured here. In future alternative methods of analysis 251 
providing more quantitative measures will be investigated. Phase contrast MRI (PC-MRI) is 252 
the conventional method of measuring flow but is less suited to measuring flow in the colon 253 
for two reasons. Firstly, tagging is less sensitive to overall subject motion than PC-MRI since 254 
the tag lines are inherently sensitive to local motion, not bulk motion. Secondly, tagging will 255 
lose sensitivity if the T1 of the material being scanned is too short as the lines will recover 256 
(and hence disappear) in the delay period. PC-MRI will lose sensitivity if the T2 of the 257 
sample is short as the signal will decay during the phase encoding period. In practice the MRI 258 
properties of normal colonic contents are likely to favour the use of tagging over PC-MRI. 259 
Finally, tagging provides an immediate assessment of the motion which would be useful for 260 
non-expert sites.  261 
A central channel of increased displacement was seen on the majority of healthy volunteers’ 262 
data, with the haustra probably impeding flow near the walls of the colon.  This may be a 263 
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biological mechanism to reduce the impact of the axial fluid flow on the anaerobicity of the 264 
more static chyme adjacent to the colon walls (where anaerobic microbiota may escape 265 
poisoning by oxygenated ileal contents entering the colon), thus preserving the mixture of 266 
aerobic and anaerobic microbiota essential for health. 267 
This study demonstrated clear changes in SBWC, ascending colon water and motion of the 268 
chyme in the ascending colon of 11 healthy volunteers at 60 mins and 120 mins following the 269 
500 ml macrogol challenge drink, a smaller stimulus than has previously been used [34]. This 270 
indicates that relatively moderate quantities of fluid passing through the small bowel and 271 
arriving in the ascending colon can trigger wall contractions and movement of the colon 272 
contents in health. However, although the SBWC and ascending colon water was also 273 
increased in the constipated group at 60 mins and 120 mins following the challenge, the 274 
motion of the contents in the ascending colon (as assessed by %COV) was not increased in 275 
this group post-ingestion. This lack of motion led to a significant difference in % COV being 276 
observed between groups at both 60 and 120 mins post-ingestion. This suggests that this 277 
parameter may successfully discriminate between healthy and constipated subjects when the 278 
ascending colon is challenged appropriately.  279 
 280 
The motility of the descending and sigmoid colon has been previously studied using 281 
manometric techniques and these have demonstrated differences in contractile activity 282 
present in IBS-C and in chronic slow transit constipation [33, 35]. IBS-C patients have 283 
normal, or even excess, antegrade and retrograde contractile activity (but this activity fails to 284 
move the contents through the colon) whereas FC patients frequently have much lower levels 285 
of contractions. However, manometry is invasive and often does not monitor the entire 286 
colonic region (particularly the proximal ascending colon where much of the mixing 287 
processes occur), and as a result is limited clinically to extreme cases, particularly for 288 
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paediatric populations.  Manometry cannot be used to study movement of the contents of a 289 
fluid filled colon as the pressure measurements become less accurate when the colonic 290 
contents become less viscous [36] and tracking of contents is not possible so that manometry 291 
cannot directly detect mixing. 292 
 293 
The main limitations of this study were the small numbers in each group.  In addition, the 294 
smaller macrogol challenge drink may not have stimulated the same type of motion seen 295 
previously with a larger challenge drink. This smaller fluid stimulus was also less likely to 296 
reach the more distal parts of the colon (descending and sigmoid) and hence may be less 297 
suitable to differentiate between subgroups of constipation patients.  298 
 299 
As the motion and mixing observed in this study was due to the stimulus of the laxative drink, 300 
data on the reproducibility of the measurement would be extremely useful and work is 301 
underway to obtain this data.  Further work is required to fully explore the potential of MRI 302 
tagging for assessment of mixing and transportation of colonic chyme including other 303 
possible physiological challenges such as a high fat meal. This potential ability to monitor 304 
non-invasively both antegrade and retrograde flow patterns could be used to assess the 305 
efficiency with which the ascending colon mixes and transports the contents and has 306 
applications in functional disorders of both constipation and diarrhoea. Allowing for data 307 
acquisition during free breathing, and using image registration techniques to remove the 308 
effects of respiration, could extend the application of this technique and allow for more 309 
sporadic motion to be investigated. Combining this technique with existing motility and 310 
volume measurements could provide increased discrimination between healthy subjects, 311 
subjects whose contractions are ineffectual at mixing and propelling the colonic contents, and 312 
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subjects in whom colonic contractions are absent, potentially allowing stratification of IBS 313 
type disorders from FC.  314 
In conclusion this study has demonstrated the use of MR tagging and a novel analysis method 315 
to study movement of the colonic content and has used this to demonstrate significant 316 
differences in the transport and mixing of colonic chyme between healthy volunteers and 317 
constipation subjects following a macrogol challenge drink.  318 
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 460 
Parameter mDIXON 
(transit and 
 volumes)‡ 
RARE  
(water 
content) 
High 
Resolution AC  
(positioning) 
TR / ms 3.0 N/A  2.4 
TE / ms TE1 = 1.07 
TE2 = 1.9 
400 1.2 
FA / º 10 90  
refocus 108 
42 
FOV / mm2 
(Freq x Phase) 
250 x 371 400 x 400 330 x 228 
Acq Resolution/ mm2 1.8 x 1.8  1.4 x 1.76 1.5 x 1.5 
Recon Resolution/ mm2 0.98 x 0.98 0.78 x 0.78 0.86 x 0.86 
Slice thickness (gap) / 
mm 
1.8 7 (0) 7 (0.58) 
SENSE 2.0 2.0 1.5 
No. Slices 111 20 8 
No. Averages 1 1 4 
Orientation Coronal Coronal Oblique 
Sagittal 
‡ Two 3D blocks were positioned coronally with a 30 mm overlap. 461 
. 462 
 463 
Table (1) Imaging parameters 464 
465 
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FIGURE LEGENDS 466 
Figure 1. Tagging applied to the ascending colon.  ‘Tags’ are the dark stripes across the 467 
image.  There is a small shift in position of these tag lines in regions of predominately fat 468 
tissue compared to water tissue (grey arrow)  (a) Typical sagittal image showing no 469 
movement within the colonic chyme - tags are straight and intact (white arrow). (b) Typical 470 
sagittal image showing movement within the colonic chyme.  Both tag distortion (white 471 
arrow) and smearing and reduction of tag intensity (red arrow) due to movement are 472 
highlighted. 473 
 474 
Figure 2. Processed images from tagged cine data showing (a) little motion (b) visible motion 475 
of colonic contents: (i) Mean pixel intensity map (calculated over 29 dynamic images). (ii) 476 
Corresponding pixel standard deviation map (calculated over 29 dynamic images).  The 477 
displayed intensity scale for the standard deviation map is 5 times smaller than the mean 478 
pixel intensity map.  The ascending colon region for each %COV calculation is outlined in 479 
red. 480 
 481 
Figure 3. (a) Individual data for MR free water in the small bowel (SBWC) at baseline, 60 482 
and 120 minutes post ingestion. (b) Individual data for MR free water in the ascending colon 483 
at baseline, 60 and 120 minutes post ingestion.  Statistically significant differences from 484 
baseline are shown (corrected for multiple comparisons). 485 
 486 
Figure 4. Tagged images showing: (a) Simultaneous antegrade (red arrow) and retrograde 487 
flow (white arrow) in ascending colon. (b) The presence of a fast moving central retrograde 488 
‘jet’ (grey arrow). (c) The reduction in tag intensity (red arrow) and complex flow in hepatic 489 
flexure of ascending colon (white arrow). 490 
 491 
 492 
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Figure 5. Individual data for the calculated % COV at baseline, 60 and 120 minutes post 493 
ingestion.  Statistically significant differences from baseline and between groups are shown 494 
(corrected for multiple comparisons). 495 
496 
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 520 
SUPPLEMENTARY INFORMATION 521 
Video 1 An example of tagged images showing little motion in the fasted 522 
ascending colon. 523 
Video 2 An example of tagged images demonstrating motion in the fluid filled 524 
ascending colon. 525 
 526 
